Primary Record
Miridesap
- In stock
- 6,723 g
- Purity
- 98.9 %
- CAS
- 224624-80-0
Compound Identifiers & Properties
- CAS
- 224624-80-0
- PubChem CID
- 125516
- SMILES
- C1C[C@@H](N(C1)C(=O)CCCCC(=O)N2CCC[C@@H]2C(=O)O)C(=O)O
- Canonical SMILES
- O=C(O)[C@H]1CCCN1C(=O)CCCCC(=O)N1CCC[C@@H]1C(=O)O
Names & Synonyms
- Miridesap
- cphpc
- miridesapum
- 224624-80-0
- CPOHPC acid
- Miridesap [USAN]
- 4avt
- CPHPC(Miridesap)
- CPHPC(Miridesap)?
- Amyloid beta inhibitor
- MIRIDESAP [INN]
- Ro 63-8695
- Miridesap (USAN/INN)
- 1,1'-hexanedioyldi-D-proline
- RefChem:818906
- (2'R)-adipoyldi-D-proline
- D05FBZ
- UNII-WO97N24A47
- AC1L2OP8
- MIRIDESAP [WHO-DD]
- WO97N24A47
- SAP binding inhibitor, Roche
- CHEMBL25263
- GSK2315698
- DTXSID00176996
- MFCD09970762
- GTPL8256
- orb1299946
- SCHEMBL1537496
- DTXCID6099487
- 1,1 -Adipoylbis(D-proline)
- HZLAWYIBLZNRFZ-VXGBXAGGSA-N
- Ro-63-8695
- C16H24N2O6
- GLXC-15410
- ZINC3972138
- GSK-2315698
- RO-638695
- CID125516
- EX-A14710
- AKOS030528069
- C16-H24-N2-O6
- compound 52 [PMID 14998318]
- DB13087
- GSK 2315698
- Serum amyloid P binding inhibitor, Roche
- 1,1'-(1,6-Dioxo-1,6-hexanediyl)bis-D-proline
- AC-35760
- BS-16672
- DA-62489
- SY310643
- HY-101861
- LS-192450
- (2R,2'R)-1,1'-Adipoylbis(pyrrolidine-2-carboxylic acid)
- CS-0022098
- NS00069687
- J1.739.100C
- Ro 63-8695|GSK2315698
- A17078
- D-Proline, 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-
- D11464
- D83697
- A901596
- Q5013646
- (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid
- 1,1'-(1,6-DIOXO-1,6-HEXANEDIYL)BIS(D-PROLINE
- (2R,2'R)-1,1'-Adipoylbis(pyrrolidine-2-carboxylicacid)
- CARBOXY PYRROLIDINE HEXANOYL PYRROLIDINE CARBOXYLATE
- D-PROLINE, 1,1'-(1,6-DIOXO-1,6-HEXANEDIYL)BIS
- (2R)-1-{6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxohexanoyl}pyrrolidine-2-carboxylic acid
- R-1-(6-(R-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid
- (2r)-1-[6-[(2r)-2-Carboxypyrrolidin-1-Yl]-6-Oxidanylidene-Hexanoyl]pyrrolidine-2-Carboxylic Acid
- (2R)-1-(6-((2R)-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid
- (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxo-hexanoyl]pyrrolidine-2-carboxylic acid
- (2R)-1-[6-[(2R)-2-Carboxypyrrolidine-1-yl]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid
- (2R)-1-[6-[(2R)-2-Carboxypyrrolizino]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid
- (2R,2'R)-1,1'-(1,6-Dioxo-1,6-hexanediyl)di(2-pyrrolidinecarboxylic acid)
- (R)-1-[6-[(R)-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]-pyrrolidine-2-carboxylic acid
- r-1-[6-[r-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine-2-carboxylic acid
- (2R,2 inverted exclamation mark R)-1,1 inverted exclamation mark -Adipoylbis(pyrrolidine-2-carboxylic Acid)
- (2R,2'R)-1,1'-(1,6-dioxohexane-1,6-diyl)dipyrrolidine-2-carboxylic acid (non-preferred name)
- (R)-1-(6-((R)-2-CARBOXY-PYRROLIDIN-1-YL)-6-OXO-HEXANOYL)PYRROLIDINE-2-CARBOXYLIC ACID
- GHE